APOE and dementia: For such studies, our findings stress the importance of simultaneously including the APOE4 allele genotyping as a standard workflow given APOE4’s compounding effects in individuals with higher levels of blood-based neurodegenerative markers and association with an increased rate of cognitive decline and, by extension, risk of developing dementias.